Approved production of Lansoprazole for injection
-
Last Update: 2020-04-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
According to the website of CFDA on April 11, the status of Lansoprazole for injection of class 3 new drugs of Jiangsu Wuzhong Pharmaceutical Group changed to "certificate preparation completed - approval document issued in Jiangsu Province" On Friday, the head of the company said the drug had been approved for production and was waiting for a notice from the Provincial Bureau "After receiving the approval documents, the company will arrange production soon, and strive to enter the bidding in the following areas." Lansoprazole is used in the treatment of gastric and duodenal ulcer At present, 7 domestic enterprises have obtained production approval documents, and more than 10 enterprises are applying for production Previously, the company has said that the product as an update of existing omeprazole products, the market is more recognized Subsequently, with the start of a new round of bidding, the company hopes to seize the time as much as possible to let the upgraded products be added to the existing products Digestive tract medication is a key development direction of Wuzhong, Jiangsu Province "To win a competitive advantage in the field of digestive system therapy" is also included in the company's three-year strategic development program In addition to omeprazole and lansoprazole, the generic application of pantoprazole sodium enteric coated tablets, a new proton pump inhibitor, for the treatment of active peptic ulcer, has just been accepted.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.